Dr. Brian Christopher Baumann, MD

Dr. Baumann practices at Neurosurgery of St Louis in Saint Louis, Missouri.

Dr. Baumann's NPI, 1841559945, was assigned on May 9, 2012. Dr. Baumann graduated from Perelman School of Med at the University of Pennsylvania in 2012. Dr. Baumann holds Illinois license 036143424.

Dr. Baumann's primary practice is Neurosurgery of St Louis, at 12855 N Forty Dr, Saint Louis, MO 63141 in Saint Louis County. The practice phone is (314) 567-6071.

Dr. Baumann's primary practice is Neurosurgery of St Louis in Saint Louis, Missouri. Dr. Baumann is also affiliated with Barnes-Jewish Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Baumann to 2 more hospitals, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baumann practices, 5 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Baumann's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Baumann's licenses on file in 2 states: Illinois and Missouri.

CMS data shows 3,653 Medicare services from Dr. Baumann across 24 procedure codes in 2024, for 212 Medicare patients. Medicare paid $344,457 for them.

CMS counts 212 Medicare patients who saw Dr. Baumann in 2024. The largest group is 65 to 74, with 111 patients. 75% of them have cancer, and 75% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Baumann's median patient age at 74, with 5% women.

In 2024, Dr. Baumann wrote 218 Medicare Part D claims for 98 patients. 86% of them were for generic drugs. CMS names the drug for 147 of them, across 5 drugs with 11 or more claims each, at $77,023 in total drug cost. In 2023, CMS named 111 claims across 3 drugs.

Dr. Baumann accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 15 papers to Dr. Baumann, published from 2017 to 2025. 2023 was the busiest year, with 6. The most frequent topics are Prostatic Neoplasms, Androgen Antagonists and Brachytherapy. Dr. Baumann has published most often in Pract Radiat Oncol. Dr. Baumann's most frequent co-authors are Jason A. Efstathiou, MD, Jeff Michael Michalski, MD and Benjamin Walker Fischer-Valuck, MD.

CMS Open Payments shows 149 general payments to Dr. Baumann from 23 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 85% of the total. Boston Scientific Corporation paid the most, $110,950.

Dr. Baumann graduated from Perelman School of Med at the University of Pennsylvania in 2012.